Literature DB >> 8566696

Metabolic studies by 1H NMR of different forms of Trypanosoma cruzi as obtained by 'in vitro' culture.

M Sanchez-Moreno1, M C Fernandez-Becerra, J J Castilla-Calvente, A Osuna.   

Abstract

By culturing Trypanosoma cruzi epimastigotes in modified Grace's medium with 10% foetal bovine serum, a significant quantity of metacyclic forms could be obtained. Transformation was observed after 8 days of culture, with metacyclic forms reaching 75%. Cultured Vero cells were infected with metacyclic forms and maintained until free-amastigote forms were obtained. Additionally, amastigote-like forms could be obtained by subjecting metacyclic cultures to heat shock. Parasites were grown with glucose as the major carbon source. The metabolites produced and excreted during culture were identified by difference proton nuclear magnetic resonance spectroscopy and quantified by enzymatic methods. The final products of glucose catabolism differed not only quantitatively but also qualitatively for the three major life-cycle stages of T. cruzi. The end products of metabolism produced by epimastigote forms were mainly acetate and pyruvate and, to a lesser extend, L-alanine and ethanol. Differences between epimastigotes and metacyclic forms were only quantitative. However, free amastigotes as well as amastigote-like forms, excreted acetate, glycerol, and pyruvate and to a lesser extent succinate, but no L-alanine or ethanol.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8566696     DOI: 10.1111/j.1574-6968.1995.tb07871.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  8 in total

1.  Biochemical characterization of new strains of Trypanosoma cruzi and T. rangeli isolates from Peru and Mexico.

Authors:  Isabel Rodríguez-González; Clotilde Marín; Ana Belén Hitos; María Jose Rosales; Ramón Gutierrez-Sánchez; Manuel Sánchez-Moreno
Journal:  Parasitol Res       Date:  2004-09-11       Impact factor: 2.289

2.  Transcriptomic analysis reveals metabolic switches and surface remodeling as key processes for stage transition in Trypanosoma cruzi.

Authors:  Luisa Berná; Maria Laura Chiribao; Gonzalo Greif; Matias Rodriguez; Fernando Alvarez-Valin; Carlos Robello
Journal:  PeerJ       Date:  2017-03-08       Impact factor: 2.984

3.  Nucleosome landscape reflects phenotypic differences in Trypanosoma cruzi life forms.

Authors:  Alex R J Lima; Christiane B de Araujo; Saloe Bispo; José Patané; Ariel M Silber; M Carolina Elias; Julia P C da Cunha
Journal:  PLoS Pathog       Date:  2021-01-26       Impact factor: 6.823

4.  Metabolic Alteration of Trypanosoma cruzi during Differentiation of Epimastigote to Trypomastigote Forms.

Authors:  Salvatore G De-Simone; Saulo C Bourguignon; Priscila S Gonçalves; Guilherme C Lechuga; David W Provance
Journal:  Pathogens       Date:  2022-02-19

5.  Proteomic and network analysis characterize stage-specific metabolism in Trypanosoma cruzi.

Authors:  Seth B Roberts; Jennifer L Robichaux; Arvind K Chavali; Patricio A Manque; Vladimir Lee; Ana M Lara; Jason A Papin; Gregory A Buck
Journal:  BMC Syst Biol       Date:  2009-05-16

6.  Transcriptional and phenotypical heterogeneity of Trypanosoma cruzi cell populations.

Authors:  Víctor Seco-Hidalgo; Luis Miguel De Pablos; Antonio Osuna
Journal:  Open Biol       Date:  2015-12       Impact factor: 6.411

7.  Improving the drug-likeness of inspiring natural products - evaluation of the antiparasitic activity against Trypanosoma cruzi through semi-synthetic and simplified analogues of licarin A.

Authors:  Thiago R Morais; Geanne A Alves Conserva; Marina T Varela; Thais A Costa-Silva; Fernanda Thevenard; Vitor Ponci; Ana Fortuna; Amílcar C Falcão; Andre G Tempone; João Paulo S Fernandes; João Henrique G Lago
Journal:  Sci Rep       Date:  2020-03-25       Impact factor: 4.379

8.  Genome-scale metabolic models highlight stage-specific differences in essential metabolic pathways in Trypanosoma cruzi.

Authors:  Isabel S Shiratsubaki; Xin Fang; Rodolpho O O Souza; Bernhard O Palsson; Ariel M Silber; Jair L Siqueira-Neto
Journal:  PLoS Negl Trop Dis       Date:  2020-10-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.